Finally, our analysis of the molecular group using the competitive risk model showed that only belonging to the triple-negative group means a worse survival rate than the reference group (Luminal with unknown Ki67), i.e., the risk of dying from breast cancer in this group is almost double that of the other groups. The gene discussed is MKI67; the disease is breast cancer.